These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 6698215)

  • 1. Hyperprolactinemic response after bromocriptine withdrawal in women with prolactin-secreting pituitary tumors.
    Maxson WS; Dudzinski M; Handwerger SH; Hammond CB
    Fertil Steril; 1984 Feb; 41(2):218-23. PubMed ID: 6698215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine treatment of women with suspected pituitary prolactin-secreting microadenomas.
    Archer DF; Lattanzi DR; Moore EE; Harger JH; Herbert DL
    Am J Obstet Gynecol; 1982 Jul; 143(6):620-5. PubMed ID: 7201244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a long-acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas.
    Tsagarakis S; Tsiganou E; Tzavara I; Nikolou H; Thalassinos N
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):593-9. PubMed ID: 7634499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment with bromocriptine of a plurihormonal pituitary adenoma secreting thyrotropin, growth hormone and prolactin.
    Shimatsu A; Murabe H; Nakamura Y; Mizuta H; Ihara C; Nakao K
    Endocr J; 1999 Feb; 46(1):159-65. PubMed ID: 10426581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
    Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tamoxifen administration on prolactin release by invasive prolactin-secreting pituitary adenomas.
    Lamberts SW; Verleun T; Oosterom R
    Neuroendocrinology; 1982; 34(5):339-42. PubMed ID: 7078703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term bromocriptine therapy may restore the inhibitory control of prolactin release in some patients with pathological hyperprolactinemia.
    Ho KY; Smythe GA; Compton PJ; Lazarus L
    Aust N Z J Med; 1985 Apr; 15(2):213-9. PubMed ID: 3927887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactive forms of serum lactogens: effects of treatment of prolactinoma patients with bromocriptine.
    Rennie PS; Prior JC; Bruchovsky N; Gout PW
    Clin Endocrinol (Oxf); 1985 Jan; 22(1):65-73. PubMed ID: 3978829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous sparsely-granulated prolactin-producing pituitary adenomas in aging rats. A prospective study of the effect of bromocriptine.
    McComb DJ; Hellmann P; Kovacs K; Scott D; Evans WS; Burdman JA; Thorner MO
    Neuroendocrinology; 1985 Sep; 41(3):201-11. PubMed ID: 4047338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawal.
    Moriondo P; Travaglini P; Nissim M; Conti A; Faglia G
    J Clin Endocrinol Metab; 1985 Apr; 60(4):764-72. PubMed ID: 3919052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization.
    Kovacs K; Stefaneanu L; Horvath E; Lloyd RV; Lancranjan I; Buchfelder M; Fahlbusch R
    Virchows Arch A Pathol Anat Histopathol; 1991; 418(5):439-46. PubMed ID: 2035258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal growth and pubertal development during bromocriptine treatment for a prolactin-secreting pituitary macroadenoma.
    Dalzell GW; Atkinson AB; Carson DJ; Sheridan B
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):169-72. PubMed ID: 3665115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromocriptine treatment of pituitary adenomas. Evaluation of withdrawal effect.
    Coculescu M; Simionescu N; Oprescu M; Alessandrescu D
    Endocrinologie; 1983; 21(3):157-68. PubMed ID: 6635518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
    Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
    Goodman LA; Chang RJ
    Obstet Gynecol; 1984 Sep; 64(3 Suppl):2S-7S. PubMed ID: 6433250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine.
    Nillius SJ; Bergh T; Lundberg PO; Stahle J; Wide L
    Fertil Steril; 1978 Dec; 30(6):710-2. PubMed ID: 729834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study.
    Molitch ME; Elton RL; Blackwell RE; Caldwell B; Chang RJ; Jaffe R; Joplin G; Robbins RJ; Tyson J; Thorner MO
    J Clin Endocrinol Metab; 1985 Apr; 60(4):698-705. PubMed ID: 3882737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine.
    Boulanger CM; Mashchak CA; Chang RJ
    Fertil Steril; 1985 Oct; 44(4):532-5. PubMed ID: 4054327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral bromocriptine in the treatment of hormonally active pituitary tumours.
    Benker G; Gieshoff B; Freundlieb O; Windeck R; Schulte HM; Lancranjan I; Reinwein D
    Clin Endocrinol (Oxf); 1986 May; 24(5):505-13. PubMed ID: 3791649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsatile thyrotropin and prolactin secretion in a patient with a mixed thyrotropin- and prolactin-secreting pituitary adenoma.
    Adriaanse R; Brabant G; Endert E; Bemelman FJ; Wiersinga WM
    Eur J Endocrinol; 1994 Feb; 130(2):113-20. PubMed ID: 8130883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.